Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, March 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 54 Mendeley
citeulike: 1 CiteULike

Summary X Dimensions citations

So far, Dimensions has found 31 publications that cite this research output.

31

The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.

Current pharmacogenomic recommendations in chronic respiratory diseases: Is there a biomarker ready for clinical implementation?

Article in Expert Review of Respiratory Medicine (November 2022)

Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs

Article in Trends in Pharmacological Sciences (September 2022)

Medication Safety in Chronic Lung Disease with Cardiac Comorbidity

Book chapter (June 2020)